EC5026 (BPN-19186) is a first-in-class, non-opioid and orally bioavailable soluble Epoxide Hydrolase (sEH) inhibitor. EC5026 shows efficacy for inflammatory and neuropathic pain. References: [1]. EicOsis Announces FDA Acceptance of IND Application for EC5026, the First Soluble Epoxide Hydrolase Inhibitor to Treat Pain.2019.

纯度：≥98%

CAS：1809885-32-2